MARK LEVENTHAL

Profile

First Name

: MARK

Middle Name

:

Last Name

: LEVENTHAL

Related Companies
Titles
Company Name
Related People
EXECUTIVE OFFICER, DIRECTOR
HUDSON HOLDING CORP
MARK BISKER, CARMINE CHIUSANO, KEITH KNOX, JOANNE LANDAU, ANTHONY SANFILIPPO, PETER ZUGSCHWERT
DIRECTOR
QUIGLEY CORP
CAROLINA ABENANTE, JASON BARR, MARK BURNETT, ROBERT V. CUDDIHY, JR., JOHN DESHAZO, MARK FRANK, LOUIS GECKEL, LOUIS GLECKEL, WARREN HIRSCH, TED KARKUS, JAMES MCCUBBIN
DIRECTOR
PROPHASE LABS, INC.
CAROLINA ABENANTE, JASON BARR, MARK BURNETT, ROBERT V. CUDDIHY, JR., JOHN DESHAZO, MARK FRANK, LOUIS GECKEL, LOUIS GLECKEL, WARREN HIRSCH, TED KARKUS, JAMES MCCUBBIN
EXECUTIVE OFFICER
NOBLESTONE CAPITAL, LLC
DANIEL MILLMAN
EXECUTIVE OFFICER, PROMOTER
NOBLESTONE REAL ESTATE OPPORTUNITIES FUND, LLC
DANIEL MILLMAN, - NOBLESTONE ASSET MANAGEMENT, LLC, - NOBLESTONE PROPERTY MANAGEMENT, LLC
EXECUTIVE OFFICER, PROMOTER
26700 LAHSER, LLC
- - NOBLESTONE CAPITAL, LLC, - - NOBLESTONE PROPERTY MANAGEMENT, LLC
DIRECTOR
NOBLESTONE OX FUND, LLC
DANIEL MILLMAN
DIRECTOR
NOBLESTONE OZ FUND, LLC
DANIEL MILLMAN
DIRECTOR
NOBLESTONE OZ FUND II, LLC
DANIEL MILLMAN
DIRECTOR
NOBLESTONE EXTENDED STAY, LLC
DANIEL MILLMAN
DIRECTOR
HOLDEN CIRCLE LLC
DANIEL MILLMAN, STEVEN RUBINSTEIN
DIRECTOR
NOBLESTONE PRINCETON LLC
DANIEL MILLMAN
DIRECTOR
HOLDEN TRIANGLE LLC
DANIEL MILLMAN, STEVEN RUBINSTEIN
EXECUTIVE OFFICER
PEACHSTONE ROCKFORD, LLC
DANIEL MILLMAN
EXECUTIVE OFFICER
NOBLESTONE PUTNAM LLC
DANIEL MILLMAN
EXECUTIVE OFFICER
NOBLESTONE AMBERLUND LLC
DANIEL MILLMAN
EXECUTIVE OFFICER
NOBLESTONE CREDIT SELECT LLC
DANIEL MILLMAN
EXECUTIVE OFFICER
NOBLESTONE CREDIT SELECT II LLC
DANIEL MILLMAN
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-12-11
D
Link
OTHER REAL ESTATE 
 
DECLINE TO DISCLOSE 
Equity 
2025-10-27 
2025-02-21
D
Link
COMMERCIAL 
 
DECLINE TO DISCLOSE 
Equity 
2024-10-27 
2024-01-22
D
Link
COMMERCIAL 
 
DECLINE TO DISCLOSE 
Equity 
2024-01-02 
2023-10-05
D
Link
COMMERCIAL 
 
DECLINE TO DISCLOSE 
Equity 
2023-09-19 
2023-07-21
D
Link
COMMERCIAL 
 
DECLINE TO DISCLOSE 
 
2023-07-05 
2022-02-16
D
Link
INVESTING 
 
NO REVENUES 
Equity 
2021-12-30 
2022-02-07
D
Link
INVESTING 
 
NO REVENUES 
Equity 
2022-01-10 
2022-02-04
D
Link
INVESTING 
 
NO REVENUES 
Equity 
2021-12-28 
2021-12-09
D
Link
INVESTING 
 
NO REVENUES 
Equity 
2021-11-24 
2021-04-14
D
Link
INVESTING 
 
NO REVENUES 
Equity 
2021-03-30 
2021-03-23
D/A
Link
INVESTING 
 
NO REVENUES 
Equity 
2020-12-29 
2021-03-23
D
Link
INVESTING 
 
NO REVENUES 
Equity 
2020-12-29 
2021-01-20
D
Link
OTHER REAL ESTATE 
 
DECLINE TO DISCLOSE 
Equity 
2020-12-30 
2020-02-26
D
Link
 
 
DECLINE TO DISCLOSE 
 
2020-02-19 
2018-11-27
D
Link
INVESTING 
 
NOT APPLICABLE 
Equity 
2018-11-16 
2015-12-28
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
$5,000,001 - $25,000,000 
Debt 
2015-12-11 
2010-03-26
D
Link
OTHER HEALTH CARE 
PHARMACEUTICAL PREPARATIONS [2834] 
$5,000,001 - $25,000,000 
Equity 
2010-03-22 
2009-10-23
D
Link
OTHER BANKING AND FINANCIAL SERVICES 
SECURITY BROKERS, DEALERS + FLOTATION COMPANIES [6211] 
DECLINE TO DISCLOSE 
Equity 
2009-10-14